Stock Fundamentals

Company Information

Company Name
Cardiol Therapeutics Inc Class A
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: CA14161Y2006
CIK: 0001702123
Currency: USD
Full Time Employees: 18
Phone: 289 910 0850
Fiscal Year End: December
IPO Date: Jan 15, 2019
Description:

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Address:

2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5

Directors & Officers

Name Title Year Born
Mr. David G. Elsley MBA President, CEO & Director NA
Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA CFO, Corporate Secretary & Director NA
Mr. Bernard Lim B.Sc. Chief Operating Officer NA
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer and Head of Research & Development 1962
Trevor Burns Investor Relations NA
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Mmcap International Inc. Spc 15.35M Mar 31, 2026 13.32% $1.79 7,247.36%
Tejara Capital Ltd 5.13M Mar 31, 2026 4.45% $2.28 0.00%
Ikarian Capital, LLC 2.73M Mar 31, 2026 2.36% $0.30 0.00%
Citadel Advisors Llc 819.90K Mar 31, 2026 0.71% $0.00 0.00%
BOOTHBAY FUND MANAGEMENT, LLC 794.88K Mar 31, 2026 0.69% $0.01 0.00%
Two Sigma Investments LLC 534.21K Mar 31, 2026 0.46% $0.00 31.28%
INTEGRITY ALLIANCE, LLC. 465.03K Mar 31, 2026 0.40% $0.02 6.90%
The Goldman Sachs Group Inc 332.40K Mar 31, 2026 0.29% $0.00 1.19%
Morgan Stanley - Brokerage Accounts 250.42K Mar 31, 2026 0.22% $0.00 -27.30%
Renaissance Technologies Corp 229.81K Mar 31, 2026 0.20% $0.00 0.00%
Jane Street Group LLC 126.96K Mar 31, 2026 0.11% $0.00 218.76%
Summit Financial LLC 104.06K Mar 31, 2026 0.09% $0.00 0.00%
Knoll Capital Management LP 100.00K Mar 31, 2026 0.09% $0.07 0.00%
We Are One Seven, LLC 100.00K Mar 31, 2026 0.09% $0.00 0.00%
1832 Asset Management L.P 100.00K Mar 31, 2026 0.09% $0.00 0.00%
Susquehanna International Group, LLP 70.40K Mar 31, 2026 0.06% $0.00 -65.45%
Geode Capital Management, LLC 52.44K Mar 31, 2026 0.05% $0.00 0.00%
JPMorgan Chase & Co 48.08K Mar 31, 2026 0.04% $0.00 0.00%
Quadrature Capital Limited 47.89K Mar 31, 2026 0.04% $0.00 0.00%
Marble Harbor Investment Counsel, LLC 39.90K Mar 31, 2026 0.03% $0.01 0.00%

Shares Statistics

Shares Outstanding: 115.27M
Shares Float: 96.50M
% Insiders: 238.20%
% Institutions: 2,466.20%
Short % Float: 1.98%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 60.70K 0.05% ▲ 15.76% Apr 30, 2026
2 Ninepoint Cannabis & Alt Health S A 12.50K 0.01% ▲ 0.00% Mar 31, 2026
3 Blackstone Alternative Multi-Strategy I 100.00 0.00% ▲ 0.00% Sep 30, 2025

Valuation Metrics

Enterprise Value: $88.87M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $116.42M
EBITDA: $-35.57M
Book Value: $0.15
Earnings/Share: $-0.27
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -78.25%
ROE (TTM): -173.96%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.16x 0.00x 0.24x N/A 0.00x
2024-12-31 4.52x 0.00x 0.22x N/A 0.00x
2023-12-31 4.36x 0.00x 0.23x N/A 0.00x
2022-12-31 6.27x 0.00x 0.16x N/A 0.00x
2021-12-31 7.53x 0.00x 0.13x N/A 0.00x
2020-12-31 5.94x 0.00x 0.17x N/A 0.00x
2019-12-31 20.81x 0.00x 0.05x -17,543.88x 0.00x
2018-12-31 11.22x 0.01x 0.10x -11.14x -0.04x
2017-12-31 14.06x 0.07x 0.11x -26.24x -0.13x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CRDL.US!